Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
| Gene | BRAF |
| Variant | D594A |
| Impact List | missense |
| Protein Effect | loss of function |
| Gene Variant Descriptions | BRAF D594A lies within the protein kinase domain of the Braf protein (UniProt.org). D594A results in a lack of Braf kinase activity (PMID: 20141835, PMID: 20978199, PMID: 28783719), promotes aneupolidy (PMID: 20978199), and in one of two cell lines demonstrated decreased transformation ability compared to wild-type Braf in culture (PMID: 29533785), but leads to activation of Mek and Erk through cooperation with activated RAS and transactivation of CRAF in cell culture and mouse models (PMID: 20141835, PMID: 20978199, PMID: 28783719). |
| Associated Drug Resistance | |
| Category Variants Paths |
BRAF mutant BRAF D594X BRAF D594A BRAF mutant BRAF inact mut BRAF D594A |
| Transcript | NM_004333.6 |
| gDNA | chr7:g.140753354T>G |
| cDNA | c.1781A>C |
| Protein | p.D594A |
| Source Database | RefSeq |
| Genome Build | GRCh38/hg38 |
| Transcript | gDNA | cDNA | Protein | Source Database | Genome Build |
|---|---|---|---|---|---|
| NM_004333 | chr7:g.140753354T>G | c.1781A>C | p.D594A | RefSeq | GRCh38/hg38 |
| NM_004333.6 | chr7:g.140753354T>G | c.1781A>C | p.D594A | RefSeq | GRCh38/hg38 |
| XM_005250045 | chr7:g.140753354T>G | c.1781A>C | p.D594A | RefSeq | GRCh38/hg38 |
| NM_004333.5 | chr7:g.140753354T>G | c.1781A>C | p.D594A | RefSeq | GRCh38/hg38 |
| NM_001354609.2 | chr7:g.140753354T>G | c.1781A>C | p.D594A | RefSeq | GRCh38/hg38 |
| NM_001354609.1 | chr7:g.140753354T>G | c.1781A>C | p.D594A | RefSeq | GRCh38/hg38 |
| NM_001378474.1 | chr7:g.140753354T>G | c.1781A>C | p.D594A | RefSeq | GRCh38/hg38 |
| NM_001378468.1 | chr7:g.140753354T>G | c.1781A>C | p.D594A | RefSeq | GRCh38/hg38 |
| Molecular Profile | Indication/Tumor Type | Response Type | Therapy Name | Approval Status | Evidence Type | Efficacy Evidence | References |
|---|